One of the highlights of attending the latest annual ACOG Clinical & Scientific meeting was joining a packed auditorium to hear Dr Ruth Lathi’s compelling lecture, “New Guidelines, New Hope for Recurrent Pregnancy Loss.” 📖 Dr. Lathi, the Director of the Multi-Specialty Recurrent Pregnancy Loss Program and Professor of Obstetrics and Gynecology at Stanford University School of Medicine, delivered details on the latest guidelines for RPL — from leveraging genetic testing to enhance diagnostic accuracy, to identifying emerging areas of research, and the role of vaginal progesterone for specific patient sub-groups. 🥼

It was especially enlightening to hear her perspective on effectively counselling patients with RPL. I was particularly delighted to connect with Dr. Lathi and share our vision for progesterone-hashtag Callavid®, spearheaded by Prof Siobhan Quenby MBE. Grateful for the chance to engage with such impactful thought leaders driving change in reproductive medicine. 🩺